In vitro and in vivo efficacies of amlodipine against Listeria monocytogenes
- 28 January 2009
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 28 (7) , 849-853
Abstract
Listeria monocytogenes causes suppurative gastritis in BALB/c mice. We investigated the effect of the antihypertensive drug amlodipine (Aml) on the growth of L. monocytogenes in vitro and in vivo. Aml showed noteworthy inhibitory action (minimum inhibitory concentration, MIC90 32 µg/ml) against Listeria strains and demonstrated cidal (minimum bactericidal concentration, MBC 64 µg/ml) activity. Aml administered orally at 2.5 µg/g in female BALB/c mice for 7 days, commencing 4 days before oral challenge (1 × 108 CFU/ml with L. monocytogenes ATCC 51774), significantly reduced bacterial counts in the stomach (P < 0.01), liver (P < 0.01), and spleen (P < 0.05), and decreased (P < 0.05) gastric lesions, neutrophilic infiltration, edema, vascular degeneration, and necrosis of gastric tissues. It caused the down-regulation of expression of inflammatory cytokines (IFN-γ, IL-1β, and TNF-α) compared to drug-free control. Aml may be used in the presence of an antibiotic as adjunct therapy that boosts the host immunity against Listeria. Further, QSAR studies might contribute in manipulating it as a lead compound for the synthesis of new, more effective non-antibiotics (helper compounds), perhaps devoid of side-effects, that could be recommended as compassionate therapy for listeriosis.Keywords
This publication has 9 references indexed in Scilit:
- The anti-inflammatory drug Diclofenac retains anti-listerial activityin vivoLetters in Applied Microbiology, 2008
- Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activitiesInternational Journal of Antimicrobial Agents, 2008
- In vitro efficacy of diclofenac against Listeria monocytogenesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis.2007
- Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodiumInternational Journal of Antimicrobial Agents, 2007
- Characteristics of the gastritis induced by Listeria monocytogenes in mice: microbiology, histopathology, and mRNA expression of inflammatory mediators with time course of infectionMicrobial Pathogenesis, 2004
- Suppurative Gastritis in BALB/c Mice Infected with Listeria monocytogenes via the Intragastric RouteJournal of Comparative Pathology, 2004
- Evaluation of Synergism between the Aminoglycoside Antibiotic Streptomycin and the Cardiovascular Agent AmlodipineBiological and Pharmaceutical Bulletin, 2004
- Amlodipine: a cardiovascular drug with powerful antimicrobial property.2003